Clinical importance of eosinophil count in nasal fluid in patients with allergic and non-allergic rhinitis

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 4, 2009, Pages 1077-1087

  Lorenzo, G D I ^a   Mansueto, P ^a   Pacor, M L ^b   Martinelli, N ^b   Rizzo, M ^a   Ditta, V ^a   Leto Barone, M S ^a   D'Alcamo, A ^a   Politi, D ^a   Pepe, I ^a   Rotolo, G ^a   Fede, G D I ^a   Caruso, C ^a   Rini, G B ^a   Corrocher, R ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Allergic rhinitis; Eosinophil count in nasal fluid; Non allergic rhinitis; Receiver operating characteristic curve

Indexed keywords

ANTIHISTAMINIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DECONGESTIVE AGENT;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG RESPONSE; EOSINOPHIL COUNT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE MUCUS; PERFORMANCE; PREDICTION; PRICK TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYMPTOM; VASOMOTOR RHINITIS;

EID: 76349123378     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200424     Document Type: Article

References (35)

1. Bousquet J, Khaltaev N, Cruz AA, et al. World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63(S):8-160.
2. Romero JN, Scadding G. Eosinophilia in nasal secretions compared to skin prick test and nasal challenge test in the diagnosis of nasal allergy. Rhinology 1992; 30:169-75.
3. Jean R, Delacourt C, Rufin P, Pfister A, Waernessyckle S, de Blic J, Scheinmann P. Nasal cytology in rhinitis children: comparison between brushing and blowing the nose. Allergy 1996; 51:932-4.
4. Juliusson S, Pipkorn U, Karlsson G, Enerbäck L. Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms. J Allergy Clin Immunol 1992; 90:898-909.
5. Scadding GK, Durham SR, Mirakian R, Jones NS, Drake-Lee AB, Ryan D, Dixon TA, Huber PA, Nasser SM; British Society for Allergy and Clinical Immunology. 2008. British Society for Allergy and Clinical Immunology. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 2008; 38:260-75.
6. Wallace DV, Dykewicz MS, Bernstein DI, et al. Joint Task Force on Practice; American Academy of Allergy; Asthma & Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008; 122(S):1-84.
7. Di Lorenzo G, Mansueto P, Melluso M, Candore G, Colombo A, Pellitteri ME, Drago A, Potestio M, Caruso C. Allergic rhinitis to grass pollen: measurement of inflammatory mediators of mast cell and eosinophils in native nasal fluid lavage and in serum out of and during pollen season. J Allergy Clin Immunol 1997; 100:832-7.
8. Ortolani C, Foresi A, Di Lorenzo G, et al. A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. FLNCO2 Italian Study Group. Allergy 1999; 54:1173-80.
9. Di Lorenzo G, Gervasi F, Drago A, Eet al. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics. Clin Exp Allergy 1999; 29:1367-77.
10. Di Lorenzo G, Drago A, Pellitteri ME, et al. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis. Int Arch Allergy Immunol 2001; 125:164-75.
11. Di Lorenzo G, Pacor ML, Pellitteri ME, et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy 2004; 34:259-67.
12. Mullarkey MF, Hill JS, Webb DDR. Allergic and non-allergic rhinitis: their characterization with attention to the meaning of nasal eosinophilia. J Allergy Clin Immunol 1980; 65:122-6.
13. Jacobs RL, Freedman PM, Boswell RN. Non-allergic rhinitis with eosinophilia (NARES syndrome). Clinical and immunologic presentation. J Allergy Clin Immunol 1981; 67:253-62.
14. Miller RE, Paradise JL, Friday GA, Fireman P, Voith D. The nasal smear for eosinophils. J Dis Child 1982; 136:1009-11.
15. Murray AB, Anderson DO. The epidemiologic relationship of clinical nasal allergy to eosinophils and to goblet cells in the nasal smear. J Allergy 1969; 43:1-8.
16. Murray AB. Nasal secretion eosinophilia in children with grass pollen hay fever. Can Med Assoc J 1971; 104:599-600.
17. Lans DM, Alfano N, Rocklin R. Nasal eosinophilia in allergic and nonallergic rhinitis: usefulness of the nasal smear in the diagnosis of allergic rhinitis. Allergy Proc 1989; 10:275-80.
18. Altman DG, Bland JM. Diagnostic tests 3: receiver operating characteristic plots. BMJ 1994; 309:188.
19. Last JM. A dictionary of epidemiology. New York: Oxford University Press, 2001.
20. Vining DJ, Gladish GW Receiver operating characteristic curves: a basic understanding. Radiographics 1992; 12:1147-54.
21. Fischer JE, Bachman LM, Jaeschke R. A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med 2003; 29:1043-51.
22. Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med 2004; 140:278-89.
23. Heinzerling L, Frew AJ, Bindslev-Jensen C, et al. Standard skin prick testing and sensitization to inhalant allergens across Europe - a survey from the GALEN network. Allergy 2005; 60:1287-300.
24. Di Lorenzo G, Pacor ML, Mansueto P, et al. Relationship between specific serum IgE to Ascaris lumbricoides and onset of respiratory symptoms in Bangladesh immigrants. Int J Immunopathol Pharmacol 2006; 19:629-38.
25. Zweig MH, Campbell G. Receiver operating characteristics (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem1993; 39:561-77.
26. Eddy DM. Probabilistic reasoning in clinical medicine: problems and opportunities. In: Kahneman D, Slovic P, Tversky A, editors. Judgment Under Uncertainty: Heuristics and Biases. Cambridge University Press; 1982; p249-267.
27. Saengpanich S, deTineo M, Naclerio RM, Baroody FM. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis. Arch Otolaryngol Head Neck Surg 2003; 129:557-62.
28. Kaszuba SM, Baroody FM, deTineo M, Haney L, Blair C, Naclerio RM. Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med 2001; 161:2581-7.
29. Mullarkey MF. Eosinophilic nonallergic rhinitis. J Allergy Clin Immunol 1988; 82:941-9.
30. Meltzer EO, Jalowayski AA, Orgel HA, Harris AG. Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray. J Allergy Clin Immunol 1998; 102:39-49.
31. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001; 86:494-508.
32. Small P, Black M, Frenkiel S. Effects of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol 1982; 70:178-82.
33. Blom HM, Godthelp T, Fokkens WJ, KleinJan A, Mulder PG, Rijntjes E. The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with nonallergic, non-infectious perennial rhinitis. J Allergy Clin Immunol 1997; 100:739-47.
34. Saleh HA, SR Durham. Perennial rhinitis. BMJ 2007; 335:502-7.
35. Settipane RA. Rhinitis: a dose of epidemiological reality. Allergy Asthma Proc 2003; 24:147-54.